Salix Coronary Plaque vs Bunkerhill MAC
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if your primary need is a near real-time, comprehensive assessment of coronary artery disease directly from CCTA scans. This tool excels at providing detailed quantification of coronary plaque, including high-risk features and stenosis, to aid in rapid diagnosis and treatment planning for patients undergoing dedicated cardiac imaging. It is ideal for cardiologists and radiologists requiring immediate, in-depth insights into coronary atherosclerosis.
View Salix Coronary Plaque →Choose Bunkerhill MAC if…
Choose Bunkerhill MAC if you aim to opportunistically identify patients at increased cardiovascular risk by detecting and quantifying mitral annular calcification (MAC) on routine, non-gated CT scans. This solution is best suited for integrating into existing workflows to screen a broader patient population for MAC, facilitating early risk identification and seamless care coordination through its integration with platforms like Carebricks. It's valuable for identifying incidental findings that warrant further cardiovascular evaluation.
View Bunkerhill MAC →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | Bunkerhill MAC |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud | Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform. |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Salix Coronary PlaqueTool A emphasizes a 'web-based software' for 'near real-time, point-of-care assessment' and an 'intuitive and easy-to-use clinical reporting platform' that integrates into existing workflows, allowing analysis, annotation, editing, and reporting within a single interface in under 10 minutes. This focus on direct, rapid physician control and a streamlined user experience gives it an edge in immediate usability for its core function. [1, 4, 6, 8]
Clinical Value
Salix Coronary PlaqueTool A offers a comprehensive and rapid analysis of coronary plaque and stenosis from CCTA scans, including the identification of high-risk plaque features, directly aiding in the diagnosis and management of coronary artery disease. This provides immediate and impactful clinical insights for a prevalent and critical condition. [JSON, 1, 4]
Pricing & Value
Salix Coronary PlaqueTool A explicitly details a per-scan assessment model with a US CPT reimbursement rate of US$950, providing a clear and transparent pathway for revenue generation and return on investment for providers. It also highlights significant time savings that can lead to additional revenue for clinics. [JSON, 4, 6, 21]
Enterprise Readiness
Bunkerhill MACTool B demonstrates superior enterprise readiness by explicitly listing HIPAA, SOC 2, and ISO 27001:2022 certifications for its platform, which are crucial for large-scale healthcare deployments. Its Carebricks platform is designed for seamless EHR integration and is actively deployed in numerous major health systems, showcasing proven scalability and robust security infrastructure. [3, 16, 22, 23]
Innovation
Bunkerhill MACTool B exhibits greater innovation by leveraging 'Generative AI for clinical reasoning and action' through its Carebricks platform, moving beyond mere detection to automate downstream tasks, provide conversational access to patient records, and integrate contextual AI for comprehensive decision support. This represents a more advanced and transformative application of AI in healthcare. [JSON, 12, 14, 15, 23, 24]
Support & Docs
Salix Coronary PlaqueTool A explicitly mentions an accessible 'Artrya Salix User Guide' on its indications for use page, indicating readily available product documentation for users. While both companies offer contact options, Tool B's public information does not detail similar direct user documentation or a dedicated support portal. [2]
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | Bunkerhill MAC |
|---|---|---|
| Product Name | Salix Coronary Plaque | Bunkerhill MAC |
| Company | Artrya Limited | Bunkerhill Health |
| Primary Clinical Focus | Coronary artery plaque and stenosis, diagnosis of coronary artery disease. | Mitral Annular Calcification (MAC), early cardiovascular risk identification. |
| Input Scan Type | CCTA scans | Routine, non-gated chest CT scans |
| Key AI Analysis | Detection and quantification of coronary plaque (atherosclerosis), identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), stenosis assessment, quantification of calcifications (calcium scoring). | AI-powered detection and quantification of Mitral Annular Calcification (MAC). |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Bunkerhill MAC.